Trials / Sponsors / GB002, Inc.
GB002, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Pulmonary Hypertension Associated With Interstitial Lung Disease | Phase 3 | 2026-02-01 |
| Active Not Recruiting | Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) Pulmonary Arterial Hypertension | Phase 3 | 2024-09-03 |
| Completed | Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) Pulmonary Arterial Hypertension | Phase 3 | 2023-12-28 |